2024 Annual Public Meeting of the Board of Directors

May 7, 2024

12:30pm-2pm (eastern)

Each year, the Reagan-Udall Foundation for the FDA conducts an annual public meeting to discuss its activities in support of the U.S. Food and Drug Administration.

The Foundation’s annual public meeting provides an opportunity for engagement between FDA and external stakeholders including patients and consumer advocates, regulated industry, health care providers, academics, and others dedicated to improving America's public health.

Commissioner's Remarks

Robert M. Califf, MD, MACC, took questions from the audience and gave remarks. Dr. Califf highlighted some of the agency's priorities, including the reorganization of the agency, tobacco enforcement, and a focus on rare diseases.






FDA Priorities Panel Discussion

Our town hall-style panel discussion featured key FDA leaders who shared their thoughts on the agency's priorities, provided updates on their specific sectors, and took questions from attendees. (Panel from left: Center for Biologics Evaluation and Research Director Dr. Peter Marks, Center for Drug Evaluation and Research Deputy Center Director Dr. Marta Sokolowska, Center for Devices and Radiological Health Director Dr. Jeffrey Shuren, Deputy Commissioner for Human Foods Jim Jones, Center for Tobacco Products Deputy Director Michele Mital, Center for Veterinary Medicine Deputy Director Dr. William Flynn, and Regulatory Affairs Deputy Associate Commissioner Douglas Stearn)


View Event Photos

Watch the Entire Annual Meeting